Company Filing History:
Years Active: 2016-2022
Title: Innovations of Douglas Ruben Call
Introduction
Douglas Ruben Call is an accomplished inventor based in Pullman, WA (US). He holds a total of 4 patents that showcase his contributions to the field of medical technology. His work primarily focuses on innovative treatment systems aimed at reducing infections in open wounds.
Latest Patents
One of his latest patents is centered around the electrochemical reduction or prevention of infections. This patent describes treatment systems, devices, articles, and associated methods of operation for treating open wounds. In one embodiment, the method involves applying a first material and a second material to be in contact with the surface of the open wound, which has a water content. A voltage differential is then applied to these materials, producing hydrogen peroxide (H2O2) at the surface through an electrochemical reaction between oxygen (O2) in the air and water (H2O) present at the surface. The voltage differential is calibrated to correspond to a concentration of the produced hydrogen peroxide that is effective in reducing or preventing bacterial infections at the surface of the open wound. Another significant patent involves Microcin MccPDI, which describes how Microcin MccPDI and bacteria harboring the mcpM gene can limit the growth of and/or kill pathogenic bacteria through proximity-dependent inhibition (PDI).
Career Highlights
Douglas Ruben Call is affiliated with Washington State University, where he contributes to research and innovation in medical technology. His work has garnered attention for its potential impact on healthcare and infection control.
Collaborations
He collaborates with notable colleagues, including Lisa Orfe and Lauren Eberhart, who contribute to his research endeavors.
Conclusion
Douglas Ruben Call's innovative patents and research at Washington State University highlight his commitment to advancing medical technology and improving patient care. His work in electrochemical treatments and bacterial inhibition represents significant strides in the fight against infections.